Description: Oral antibiotic prophylaxis reduces spontaneous bacterial peritonitis occurrence and improves short-term survival in cirrhosis: a meta-analysis. Am J Gastroenterol 2009; 104:993. Loomba R, Wesley R, Bain A, et al. Role of fluoroquinolones in the primary prophylaxis of spontaneous bacterial peritonitis: meta-analysis.
Description: Secondary prophylaxis of SBP is unnecessary in patients whose cirrhosis improves with specific measures with disappearance of ascites (i.e., alcohol withdrawal in alcoholic patients or antiviral treatment), antibiotic prophylaxis may not be necessary in Child‐Pugh A patients with UGB, 19 and type or need of prophylactic antibiotics in ...
Description: According to investigators, approximately 2.5% of all hospitalizations in patients with liver cirrhosis are due to spontaneous bacterial peritonitis. Based on the findings of the review, there is very low-certainty evidence concerning antibiotic prophylaxis.
Description: WASHINGTON – Patients with cirrhosis who received secondary prophylaxis for spontaneous bacterial peritonitis had better outcomes than patients who received primary prophylaxis in a review of more than 300 patients at 14 North American centers. The mortality rate during follow-up of cirrhotic patients hospitalized while on primary prophylaxis against spontaneous bacterial peritonitis (SBP ...
Description: Spontaneous bacterial peritonitis (SBP) is the development of a bacterial infection in the peritoneum, despite the absence of an obvious source for the infection. It is specifically an infection of the ascitic fluid – an increased volume of peritoneal fluid. Ascites is most commonly a complication of cirrhosis of the liver. It can also occur in patients with nephrotic syndrome.
Description: SBP is a significant cause of morbidity and mortality in patients with cirrhosis, with the mortality rate approaching 20% to 40%.2 Of the 32% to 34% of cirrhotic patients who present with, or develop, a bacterial infection during their hospitalization, 25% are due to SBP. 1 Changes in gut motility, mucosal defense, and microflora allow for ...
Description: SBP.(1,4) However, in the absence of additional risk factors, incidence of SBP is relatively low ( 20% at 1 TABLE 1. Current Indications of Antibiotic Prophylaxis in Cirrhosis* Indication Antibiotic and Dose Duration Secondary prophylaxis Norﬂoxacin 400 mg/day or ciproﬂoxacin 500 mg/day PO Until liver transplantation or death
Description: should receive long-term prophylaxis with daily norfloxacin (or trimethoprim/ sulfamethoxazole). (Class I, Level A) 36. In patients with cirrhosis and ascites, longterm use of norfloxacin (or trimethoprim/ sulfamethasoxazole) can be justified if the ascitic fluid protein
Description: with newly diagnosed cirrhosis are screening for varices and HCC (see “S creening, diagnosis, and management of HCC” ) . Screening for gastroesophageal varices and primary prophylaxis of variceal hemorrhage A n esophagogastroduodenoscopy (EGD) should be performed once the diagnosis of cirrhosis is established (4 – 6) . ! e objective
Copyright © 2017